BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 2021;16:55. [PMID: 34384464 DOI: 10.1186/s13024-021-00474-z] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
Number Citing Articles
1 Fu Y, Guo Z, Wang Y, Zhang H, Zhang F, Xu Z, Shen X, Roppongi RT, Mo S, Gu W, Nakajima T, Tsushima Y. Single-nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID-19 and Alzheimer’s disease. Front Immunol 2022;13:967356. [DOI: 10.3389/fimmu.2022.967356] [Reference Citation Analysis]
2 Li L, Yu X, Sheng C, Jiang X, Zhang Q, Han Y, Jiang J. A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives. Transl Neurodegener 2022;11. [DOI: 10.1186/s40035-022-00315-z] [Reference Citation Analysis]
3 Shang Y, Sun X, Chen X, Wang Q, Wang EJ, Miller E, Xu R, Pieper AA, Qi X. A CHCHD6–APP axis connects amyloid and mitochondrial pathology in Alzheimer’s disease. Acta Neuropathol. [DOI: 10.1007/s00401-022-02499-0] [Reference Citation Analysis]
4 Shokhirev MN, Johnson AA. An integrative machine-learning meta-analysis of high-throughput omics data identifies age-specific hallmarks of Alzheimer's disease. Ageing Res Rev 2022;:101721. [PMID: 36029998 DOI: 10.1016/j.arr.2022.101721] [Reference Citation Analysis]
5 Gomes P, Tzouanou F, Skolariki K, Iakovou AV, Noguera-Ortiz C, Tsirtsaki K, Waites CL, Vlamos P, Sousa N, Costa-Silva B, Kapogiannis D, Sotiropoulos I. Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: Implications for disease progression, diagnosis and treatment. Exp Neurol 2022;:114183. [PMID: 35952764 DOI: 10.1016/j.expneurol.2022.114183] [Reference Citation Analysis]
6 Roca-martinez J, Lazar T, Gavalda-garcia J, Bickel D, Pancsa R, Dixit B, Tzavella K, Ramasamy P, Sanchez-fornaris M, Grau I, Vranken WF. Challenges in describing the conformation and dynamics of proteins with ambiguous behavior. Front Mol Biosci 2022;9:959956. [DOI: 10.3389/fmolb.2022.959956] [Reference Citation Analysis]
7 Ganne A, Balasubramaniam M, Griffin WST, Shmookler Reis RJ, Ayyadevara S. Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease. Pharmaceutics 2022;14:1354. [DOI: 10.3390/pharmaceutics14071354] [Reference Citation Analysis]
8 Varesi A, Carrara A, Pires VG, Floris V, Pierella E, Savioli G, Prasad S, Esposito C, Ricevuti G, Chirumbolo S, Pascale A. Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview. Cells 2022;11:1367. [PMID: 35456047 DOI: 10.3390/cells11081367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sun X, Sun H, Han X, Chen PC, Jiao Y, Wu Z, Zhang X, Wang Z, Niu M, Yu K, Liu D, Dey KK, Mancieri A, Fu Y, Cho JH, Li Y, Poudel S, Branon TC, Ting AY, Peng J. Deep Single-Cell-Type Proteome Profiling of Mouse Brain by Nonsurgical AAV-Mediated Proximity Labeling. Anal Chem 2022. [PMID: 35315655 DOI: 10.1021/acs.analchem.1c05212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Golde TE. Alzheimer’s disease – the journey of a healthy brain into organ failure. Mol Neurodegeneration 2022;17. [DOI: 10.1186/s13024-022-00523-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
11 Schumacher-schuh A, Bieger A, Borelli WV, Portley MK, Awad PS, Bandres-ciga S. Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases. Front Neurol 2022;12:792227. [DOI: 10.3389/fneur.2021.792227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hu B, Duan S, Wang Z, Li X, Zhou Y, Zhang X, Zhang YW, Xu H, Zheng H. Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders. Front Aging Neurosci 2021;13:789834. [PMID: 34867307 DOI: 10.3389/fnagi.2021.789834] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Lu Y, Li K, Hu Y, Wang X. Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer's Disease. Front Immunol 2021;12:768966. [PMID: 34804058 DOI: 10.3389/fimmu.2021.768966] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 San Segundo-Acosta P, Montero-Calle A, Jernbom-Falk A, Alonso-Navarro M, Pin E, Andersson E, Hellström C, Sánchez-Martínez M, Rábano A, Solís-Fernández G, Peláez-García A, Martínez-Useros J, Fernández-Aceñero MJ, Månberg A, Nilsson P, Barderas R. Multiomics Profiling of Alzheimer's Disease Serum for the Identification of Autoantibody Biomarkers. J Proteome Res 2021;20:5115-30. [PMID: 34628858 DOI: 10.1021/acs.jproteome.1c00630] [Reference Citation Analysis]
15 Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J. Correction to: Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 2021;16:72. [PMID: 34670601 DOI: 10.1186/s13024-021-00493-w] [Reference Citation Analysis]